Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00202
|
|||||
| Drug Name |
D-mannose
|
|||||
| Synonyms |
Mannose
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Urinary tract infections [ICD11: GC08] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H12O6
|
|||||
| Canonical SMILES |
C(C1C(C(C(C(O1)O)O)O)O)O
|
|||||
| InChI |
InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6?/m1/s1
|
|||||
| InChIKey |
WQZGKKKJIJFFOK-QTVWNMPRSA-N
|
|||||
| CAS Number |
CAS 530-26-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 180.16 | Topological Polar Surface Area | 110 | ||
| Heavy Atom Count | 12 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
-2.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103583168
, 104346557
, 124801461
, 125310805
, 126523054
, 126631771
, 127844171
, 129621449
, 131317572
, 131465283
, 134228441
, 134228449
, 134958993
, 134984714
, 134999617
, 135136220
, 137002180
, 139416018
, 14720290
, 15066909
, 15322061
, 22396012
, 24277482
, 24882738
, 24882739
, 24896601
, 24897068
, 26737907
, 29217866
, 29286577
, 3135279
, 3459
, 53788969
, 56311267
, 56320690
, 56323500
, 56475044
, 57330235
, 57651949
, 79376412
, 8027205
, 8164149
, 824810
, 838927
, 85164870
, 87572161
, 91700886
, 92298697
, 92710545
, 93375117
|
|||||
| ChEBI ID |
ChEBI:4208
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | SGLT4 | Transporter Info | Sodium/glucose cotransporter 4 | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT03497598) Preventing Recurrent Urinary Tract Infections With -D-mannose | |||||
| 2 | SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci. 2005 Jan 14;76(9):1039-50. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.